1. Home
  2. MAIA vs MGLD Comparison

MAIA vs MGLD Comparison

Compare MAIA & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • MGLD
  • Stock Information
  • Founded
  • MAIA 2018
  • MGLD 1996
  • Country
  • MAIA United States
  • MGLD United States
  • Employees
  • MAIA N/A
  • MGLD N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • MGLD Finance/Investors Services
  • Sector
  • MAIA Health Care
  • MGLD Finance
  • Exchange
  • MAIA Nasdaq
  • MGLD Nasdaq
  • Market Cap
  • MAIA 65.9M
  • MGLD 60.7M
  • IPO Year
  • MAIA 2022
  • MGLD N/A
  • Fundamental
  • Price
  • MAIA $2.13
  • MGLD $1.34
  • Analyst Decision
  • MAIA
  • MGLD
  • Analyst Count
  • MAIA 0
  • MGLD 0
  • Target Price
  • MAIA N/A
  • MGLD N/A
  • AVG Volume (30 Days)
  • MAIA 163.9K
  • MGLD 2.6K
  • Earning Date
  • MAIA 11-12-2024
  • MGLD 11-19-2024
  • Dividend Yield
  • MAIA N/A
  • MGLD N/A
  • EPS Growth
  • MAIA N/A
  • MGLD N/A
  • EPS
  • MAIA N/A
  • MGLD N/A
  • Revenue
  • MAIA N/A
  • MGLD $32,511,000.00
  • Revenue This Year
  • MAIA N/A
  • MGLD N/A
  • Revenue Next Year
  • MAIA N/A
  • MGLD N/A
  • P/E Ratio
  • MAIA N/A
  • MGLD N/A
  • Revenue Growth
  • MAIA N/A
  • MGLD N/A
  • 52 Week Low
  • MAIA $0.82
  • MGLD $0.78
  • 52 Week High
  • MAIA $5.99
  • MGLD $1.92
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 33.62
  • MGLD 51.79
  • Support Level
  • MAIA $2.42
  • MGLD $1.15
  • Resistance Level
  • MAIA $3.48
  • MGLD $1.47
  • Average True Range (ATR)
  • MAIA 0.29
  • MGLD 0.08
  • MACD
  • MAIA -0.06
  • MGLD 0.01
  • Stochastic Oscillator
  • MAIA 1.46
  • MGLD 63.89

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

Share on Social Networks: